Key facts
- This page summarizes Daniel Antonio Perez's Form 4 filing for Hinge Health, Inc. (HNGE).
- 15 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 11 Sep 2026, 19:35.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Conversion of derivative security
Sale
Sale
Sale
Sale
Sale
Gift
Conversion of derivative security
Sale
Sale
Sale
Sale
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Conversion of derivative security
Conversion of derivative security
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and his spouse on June 11, 2026.
Footnote F2
Represents the weighted average sale price. The lowest price at which shares were sold was $87.44 and the highest price at which shares were sold was $88.43. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Footnote F3
Represents the weighted average sale price. The lowest price at which shares were sold was $88.50 and the highest price at which shares were sold was $89.495. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Footnote F4
Represents the weighted average sale price. The lowest price at which shares were sold was $89.51 and the highest price at which shares were sold was $90.50. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Footnote F5
Represents the weighted average sale price. The lowest price at which shares were sold was $90.51 and the highest price at which shares were sold was $91.50. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Footnote F6
Represents the weighted average sale price. The lowest price at which shares were sold was $91.53 and the highest price at which shares were sold was $91.76. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Footnote F7
Represents the weighted average sale price. The lowest price at which shares were sold was $88.44 and the highest price at which shares were sold was $89.43. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Footnote F8
Represents the weighted average sale price. The lowest price at which shares were sold was $89.44 and the highest price at which shares were sold was $90.43. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Footnote F9
Represents the weighted average sale price. The lowest price at which shares were sold was $90.44 and the highest price at which shares were sold was $91.42. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Footnote F10
Represents the weighted average sale price. The lowest price at which shares were sold was $91.45 and the highest price at which shares were sold was $91.72. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Footnote F11
Each share of Class B Common Stock is convertible into one share of the lssuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
Footnote F12
Excludes 3,777,002 performance-based restricted stock units held by the Reporting Person.